This report, The changing nature of diagnosis, sets out the implications for practitioners and patients of the technological ...

Heather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a ...

The rise of at-home health “self tests” promises user empowerment, convenience, and early detection all wrapped up in slick ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn had the opportunity to comment for radio coverage of the ...

Synthetic data is artificially generated data that reflects the properties and relationships found in real data. While synthetic data can play an important role in AIaMD development, its use in ...

New science and technology can transform healthcare, offering exciting opportunities for better and more personalised prediction, prevention and treatment of disease. Our primary focus continues to be ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

Next steps in the sequence: the implications of whole genome sequencing for health in the UK is the first comprehensive guide to the clinical impact of these transformational technologies, and makes ...

Published in 2019, this reports examines the evidence and readiness for clinical implementation of polygenic scores from the perspective of cardiovascular disease prevention.

PHG Foundation recognised the potential of NIPT to improve antenatal care but also saw the many ethical issues it raised.